NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Droia Ventures

Droia Ventures

Meise, Flandersdroiaventures.com

Overview

Droia Ventures is a specialist biotech investor with an exclusive focus on therapeutics for oncology and genetic disease . Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients . With a team of seasoned scientists, entrepreneurs and investment professionals, Droia builds companies to save patients' lives .

Year Founded

2011

Portfolio Companies

27

Investments

Droia Ventures investments
CompanyDateStageLead
Unnatural ProductsMar 2026Series BCo-investor
Protego BiopharmaDec 2025Series BCo-investor
Actio BiosciencesJun 2025Series B-
Hillstar BioMar 2025Series ALead
Alesta TherapeuticsJan 2025Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersMeise, Flanders
Year Founded2011

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.